These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23590351)

  • 1. Use of APTIMA Combo 2: the experience of a child advocacy center.
    Leder MR; Leber AL; Marcon MJ; Scribano PV
    J Child Sex Abus; 2013; 22(3):297-311. PubMed ID: 23590351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Crucitti T; De Deken B; Smet H; Cuylaerts V; Abdellati S; Vuylsteke B
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):385-6. PubMed ID: 23598167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nucleic acid amplification tests and culture techniques in the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in victims of suspected child sexual abuse.
    Kellogg ND; Baillargeon J; Lukefahr JL; Lawless K; Menard SW
    J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):331-9. PubMed ID: 15581779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
    Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
    Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
    Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
    J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test.
    Van Der Pol B; Taylor SN; Liesenfeld O; Williams JA; Hook EW
    Sex Transm Dis; 2013 Mar; 40(3):247-50. PubMed ID: 23407470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting.
    Ho MK; Lo JY; Lo AC; Cheng FK; Chan FK
    Sex Transm Infect; 2009 Sep; 85(5):322-5. PubMed ID: 19406739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.
    Black CM; Driebe EM; Howard LA; Fajman NN; Sawyer MK; Girardet RG; Sautter RL; Greenwald E; Beck-Sague CM; Unger ER; Igietseme JU; Hammerschlag MR
    Pediatr Infect Dis J; 2009 Jul; 28(7):608-13. PubMed ID: 19451856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.
    Lowe P; O'Loughlin P; Evans K; White M; Bartley PB; Vohra R
    J Clin Microbiol; 2006 Jul; 44(7):2619-21. PubMed ID: 16825397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the BD Viper System with XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens.
    Mushanski LM; Brandt K; Coffin N; Levett PN; Horsman GB; Rank EL
    Sex Transm Dis; 2012 Jul; 39(7):514-7. PubMed ID: 22706212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Gen-Probe APTIMA-based Neisseria gonorrhoeae and Chlamydia trachomatis confirmatory testing in a metropolitan setting of high disease prevalence.
    Munson E; Boyd V; Czarnecka J; Griep J; Lund B; Schaal N; Hryciuk JE
    J Clin Microbiol; 2007 Sep; 45(9):2793-7. PubMed ID: 17581933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection.
    Crucitti T; Jespers V; Van Damme L; Van Dyck E; Buvé A
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):97-9. PubMed ID: 16860515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
    Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
    J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.
    Chernesky MA; Martin DH; Hook EW; Willis D; Jordan J; Wang S; Lane JR; Fuller D; Schachter J
    J Clin Microbiol; 2005 Jan; 43(1):127-31. PubMed ID: 15634960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.
    Chernesky M; Jang D; Luinstra K; Chong S; Smieja M; Cai W; Hayhoe B; Portillo E; Macritchie C; Main C; Ewert R
    J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasma genitalium, Chlamydia trachomatis, and Neisseria gonorrhoeae Detected With Aptima Assays Performed on Self-Obtained Vaginal Swabs and Urine Collected at Home and in a Clinic.
    Chernesky M; Jang D; Martin I; Arias M; Shah A; Smieja M; Ratnam S; Getman D; Schachter J
    Sex Transm Dis; 2019 Sep; 46(9):e87-e89. PubMed ID: 31415336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Boyadzhyan B; Yashina T; Yatabe JH; Patnaik M; Hill CS
    J Clin Microbiol; 2004 Jul; 42(7):3089-93. PubMed ID: 15243065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of APTIMA Combo 2 assay to the diagnosis of gonorrhoea in genitourinary medicine setting.
    Moss S; Mallinson H
    Int J STD AIDS; 2007 Aug; 18(8):551-4. PubMed ID: 17686218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae.
    Chernesky MA; Jang DE
    Expert Rev Mol Diagn; 2006 Jul; 6(4):519-25. PubMed ID: 16824026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic.
    Hoebe CJ; Rademaker CW; Brouwers EE; ter Waarbeek HL; van Bergen JE
    Sex Transm Dis; 2006 Aug; 33(8):491-5. PubMed ID: 16547452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.